Show
Sort by
-
Population pharmacokinetic modeling of canagliflozin in healthy volunteers and patients with type 2 diabetes mellitus
-
Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries
-
Modeling continuous bounded outcome scores using beta regression with NONMEM (R) VII
-
Shrinkage in nonlinear mixed-effects population models: quantification, influencing factors, and impact
-
A time scaling approach to develop an in vitro-in vivo correlation (IVIVC) model using a convolution-based technique
-
Impact of low percentage of data below the quantification limit on parameter estimates of pharmacokinetic models
-
A nonlinear mixed effects IVIVC model for multi-release drug delivery systems